P2.04-36 Immune Checkpoint Inhibition for Non-Small Cell Lung Cancer (NSCLC) in Patients with Pulmonary Tuberculosis or Hepatitis B

G. Chan, Y.Q. Huang,Y. Ang, W.Q. Chong,V. Muthu,A. Wong,R. Soo

JOURNAL OF THORACIC ONCOLOGY(2019)

引用 1|浏览2
暂无评分
关键词
Immune-checkpoint inhibitors,Tuberculosis,Hepatitis B
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要